Skip to main content
. 2022 Jul 14;25(5):875–879. doi: 10.4103/aian.aian_1109_21

Table 3.

The Risk Factor Profile Observed in 145 Cases of CVST

Risk Factors Number of Patients Percentage
Polycythemia 34 23.4%
High Homocysteine Levels 28 19.31%
ANA - Profile 12 8.27%
ANA - Global 07 4.82%
Puerperium 07 4.82%
APLA 04 2.8%
ANCA 02 1.37%
OCP Use 01 2.3%

CVST=Cerebral Venous Sinus Thrombosis, ANA=Antinuclear Antibody, APLA=Antiphospholipid Antibody, ANCA=Antineutrophil Cytoplasmic Antibodies, OCP=Oral Contraceptive Pills